ResMed Inc. vs 22nd Century Group Inc — how do they compare? ResMed Inc. trades at $197.45 (market cap $28.81B), while 22nd Century Group Inc trades at $4.25 (market cap $1.49M). The key difference: ResMed Inc. is far larger — about 19335.6× 22nd Century Group Inc's market cap, and ResMed Inc. pays a 1.21% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals.
| RMD | XXII | |
|---|---|---|
Market Cap | $28.81B | $1.49M |
Sector | Health | Technology |
52-Week High | $293.73 | $1.07K |
52-Week Low | $182.82 | $3.90 |
Enterprise Value | $27.99B | -$6.74M |
Dividend Yield | 1.21% | — |
Trailing returns across standard periods
Latest headlines on both assets
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →